results

Varonis Announces Third Quarter 2025 Financial Results

Annual recurring revenues increased 18% year-over-yearSaaS ARR as a percentage of total ARR was approximately 76%Year-to-date cash from operations generated…

2 months ago

LUMOSA THERAPEUTICS ANNOUNCES POSITIVE RESULTS FROM LT3001(INTRAVENOUS ODATROLTIDE) PHASE 2B CLINICAL TRIAL IN ACUTE ISCHEMIC STROKE

Results presented at the 17th World Stroke Congress (WSC 2025) LT3001(Odatroltide)-202 phase 2b study met primary endpoint. No symptomatic intracranial…

2 months ago

Elixir Medical Announces Significant Late Breaking Clinical Results for DynamX Bioadaptor Demonstrating Nearly 50% Reduction in Coronary Event Rates vs. Current PCI Standard of Care

Results were presented at the Transcatheter Cardiovascular Therapeutics (TCT) Conference 2025 in San Francisco on October 27, 2025 DynamX® bioadaptor…

2 months ago

Progyny, Inc. Announces Details for Its Third Quarter 2025 Results Report

October 23, 2025 13:08 ET  | Source: Progyny, Inc. NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq:…

2 months ago

CVRx to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call on Nov. 5, 2025

October 22, 2025 16:30 ET  | Source: CVRx, Inc. MINNEAPOLIS, Oct. 22, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX)…

2 months ago

Duck Creek Technologies Wins IDC FinTech Real Results Award for Insurance Transformation

Recognition highlights Duck Creek's measurable impact on HDFC ERGO's digital transformation journey BOSTON, Oct. 21, 2025 /PRNewswire/ -- Duck Creek Technologies,…

2 months ago

AV-Comparatives Releases Latest Security Test Results for Enterprise and Consumer Markets

INNSBRUCK, Austria, Oct. 21, 2025 /PRNewswire/ -- Independent evaluations highlight trusted cybersecurity solutions, with registration now open for the CARO…

2 months ago

IO Biotech Presents Phase 3 Results for Cylembio plus KEYTRUDA (pembrolizumab) in First-line Advanced Melanoma at ESMO 2025

October 20, 2025 02:30 ET  | Source: IO Biotech Cylembio plus pembrolizumab achieved a clinically relevant 19.4 months median progression…

3 months ago

Bank of America Reports Third Quarter 2025 Financial Results

CHARLOTTE, N.C., Oct. 15, 2025 /PRNewswire/ -- Bank of America reported its third quarter 2025 financial results today. The news…

3 months ago

Euro NCAP to Launch New 2025 Car Safety Results

WhatLatest Euro NCAP results published online and via social media.WhenWednesday 15 October - 11:00 a.m. CEST.WhereGo to Euro NCAP's Press Releases or…

3 months ago